ENG
KOR
CONTACT
Our Company
About Us
R&D Centers
PBMS
Our Science
Biosimilar & First-in-Class Antibody
Development Pipeline
PBP1510
PBP1710
IDC001
Vaccine
R&D Technology
Investors
Stock Information
Listing Information
Stock Charts
Financial Information
Overview
Public Disclosures
Audited Financial Statements
Annual Report
Media
Newsroom
Events
PR Materials
Careers
INVESTORS
Stock Information
Listing Information
Number of shares issued
Total
12,019,231
Common
12,019,231
Share Capital (USD)
537,568,044.95
Listing Date of Entity
5 February 2021